TBIO Insider Trading - Telesis Bio, Inc.

Deler fremragende	1,801,848 shares
Insideraktier	5.468.325 shares
Total Insiders	40

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

2829 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )

2777 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Telesis Bio, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
Atlas Venture Associates VIII, Inc. 10% Owner - [10%]	3.922.010	217.889
Atlas Venture Associates VIII, L.P. 10% Owner - [10%]	3.922.010	217.889
Atlas Venture Fund VIII, L.P. 10% Owner - [10%]	3.922.010	217.889
Baupost Group Llc/ma 10% Owner - [10%]	0	0
Ann Barbier	150.000
Baupost Group GP, L.L.C. 10% Owner - [10%]	0	0
Daniella Beckman	0
Burgess Paul D. Chief Operating Officer, CLO - [O]	0	0
Paula Cloghessy See Remarks - [O]	102.480	5.693
George Demetri	0
Jean Francois Formela Director - [D]	0	0
Brian Fenton Chief Business Officer - [O]	250.990	13.944
Plc Glaxosmithkline 10% Owner - [10%]	3.697.912	205.440

Insider	Aktier Ejet	Dele Justeret
Gallagher Brian M. Jr. Director - [D]	3.697.912	205.440
Michael Heartlein See Remarks - [O]	36.000	2.000
Owen Hughes Director - [D]	0	0
Seth A Klarman 10% Owner - [10%]	0	0
Daniel Lynch Director - [D]	643.650	35.758
Lim Richard J. 10% Owner - [10%]	1.458.424	81.024
MRL Ventures Fund LLC 10% Owner - [10%]	1.873.503	104.084
Meyer Robert J.	0
Claudio Nessi 10% Owner - [10%]	1.458.424	81.024
Omega Fund IV G.P. Manager, Ltd. 10% Owner - [10%]	1.458.424	81.024
Omega Fund IV GP, L.P. 10% Owner - [10%]	1.458.424	81.024
Omega Fund IV, L.P. 10% Owner - [10%]	1.458.424	81.024
Omega Fund V GP Manager, Ltd. 10% Owner - [10%]	1.458.424	81.024

Insider	Aktier Ejet	Dele Justeret
Omega Fund V GP, L.P. 10% Owner - [10%]	1.458.424	81.024
Omega Fund V, L.P. 10% Owner - [10%]	1.458.424	81.024
Anne-Mari Paster 10% Owner - [10%]	1.458.424	81.024
Robert M Plenge	0
Ronald C JR Renaud Chief Executive Officer, Director - [D] [O]	0	0
Sanofi 10% Owner - [10%]	75.668.031	4.203.780
Schroer John R.	150.000
Shire Human Genetic Therapies, Inc. 10% Owner - [10%]	0	0
plc Shire 10% Owner - [10%]	7.078.945	393.275
Brendan Smith	0
Otello Stampacchia 10% Owner - [10%]	1.458.424	81.024
Everett Rand Sutherland	0
Pharmaceutical Co Ltd Takeda 10% Owner - [10%]	0	0
Richard Wooster	150.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TBIO / Telesis Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2021-09-14	Sanofi	51.467.612	38,0000	2.859.312	684,0000	1.955.769.256	2	239.04	-1.272.279.555	-65,05
2021-09-14	Sanofi	20.515.985	38,0000	1.139.777	684,0000	779.607.430
2020-06-26	BAUPOST GROUP LLC/MA	500.000	22,0000	27.778	396,0000	11.000.000
2018-07-02	GLAXOSMITHKLINE PLC	269.230	13,0000	14.957	234,0000	3.499.990
2018-07-02	MRL Ventures Fund LLC	25.000	13,0000	1.389	234,0000	325.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TBIO / Telesis Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2021-09-16	2021-09-14	4/A	BAUPOST GROUP LLC/MA See footnote 1 and 2	TBIO	Common Stock	J - Other	I		38,0000	-18.044.239	-685.681		0
2021-09-14	2021-09-14	4	Sutherland Everett Rand	TBIO	Stock Option (right to buy)	S - Sale	D	16,37		-300.000		0
2021-09-14	2021-09-14	4	Smith Brendan	TBIO	Stcok Option (right to buy)	S - Sale	D	19,23		-201.800		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	8,34		-89.996		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7,39		-1.071.009		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stcok Option (right to buy)	S - Sale	D	23,82		-325.000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7,66		-525.000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7,95		-500.000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Common Stock	S - Sale	I		38,0000	-40.909	-1.555		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock	S - Sale	I		38,0000	-409.913	-15.577		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Common Stock	S - Sale	D		38,0000	-503.231	-19.123		0
2021-09-14	2021-04-07	4/A	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7,39		-9.026		1.071.009
2021-09-14	2021-04-07	4/A	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7,3900	9.026	67		503.231
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	23,82		-90.000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7,95		-150.000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7,66		-150.000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	8,34		-69.953		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7,39		-219.652		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Common Stock	S - Sale	D		38,0000	-71.833	-2.730		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	10,20		-18.900		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	12,36		-37.800		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	10,20		-18.900		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	7,49		-37.800		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (righ to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	10,20		-18.900		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	7,39		-38.135		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Common Stock	S - Sale	D		38,0000	-29.860	-1.135		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	10,15		-37.800		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	8,34		-37.800		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	10,20		-18.900		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		38,0000	-2.055.063	-78.092		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	10,15		-37.800		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	20,43		-20.000		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	15,33		-18.900		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	10,20		-18.900		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	7,39		-67.995		0
2021-09-14	2021-09-14	4	Sanofi	TBIO	Common Stock, par value $0.001 per share	P - Purchase	D		38,0000	20.515.985	779.607		75.668.031
2021-09-14	2021-09-14	4	Sanofi	TBIO	Common Stock, par value $0.001 per share	P - Purchase	D		38,0000	51.467.612	1.955.769		55.152.046
2021-08-12		3	Sanofi	TBIO	Common Stock		D						3.684.434
2021-06-17	2021-06-16	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock (right to buy)	A - Award	D	20,43		20.000		20.000
2021-06-16	2021-06-16	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	20,43		20.000		20.000
2021-06-16	2021-06-16	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	20,43		20.000		20.000
2021-06-16	2021-06-16	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	20,43		20.000		20.000
2021-06-16	2021-06-16	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	20,43		20.000		20.000
2021-06-16	2021-06-16	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	20,43		20.000		20.000
2021-04-20	2021-04-19	4	Smith Brendan	TBIO	Stock Option (Right to Buy)	A - Award	D	19,23		201.800		201.800
2021-04-09	2021-04-07	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7,39		-9.026		1.071.009
2021-04-09	2021-04-07	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7,3900	9.026	67		503.321
2021-03-23	2021-03-22	4	Sutherland Everett Rand	TBIO	Stock Option (right to buy)	A - Award	D	16,37		300.000		300.000
2021-03-09	2021-03-09	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	23,82		325.000		325.000
2021-03-09	2021-03-09	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	23,82		70.000		70.000
2021-03-09	2021-03-09	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	23,82		70.000		70.000
2021-03-09	2021-03-09	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	23,82		90.000		90.000
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	8,34		-1		89.996
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7,39		-5.638		1.080.035
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		8,3400	1	0		494.205
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7,3900	5.638	42		494.204
2020-12-23	2020-12-22	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25,8825	-2.700	-70		43.940
2020-12-23	2020-12-22	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25,0421	-79.865	-2.000		46.640
2020-12-23	2020-12-21	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25,5046	-56.536	-1.442		126.505
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	8,34		-3		89.997
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7,39		-53.004		1.085.673
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		8,3400	3	0		488.566
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7,3900	53.004	392		488.563
2020-08-27	2020-08-27	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		14,3822	-10.097	-145		3.833.122
2020-08-27	2020-08-26	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		14,7979	-44.381	-657		3.843.219
2020-08-27	2020-08-25	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		15,0003	-34.410	-516		3.887.600
2020-06-30	2020-06-30	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20,6800	-6.824.992	-141.141		0
2020-06-30	2020-06-26	4	BAUPOST GROUP LLC/MA See footnote 1 and 2.	TBIO	Common Stock	P - Purchase	I		22,0000	500.000	11.000		18.044.239
2020-06-17	2020-06-16	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-17	2020-06-16	4	LYNCH DANIEL	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-17	2020-06-16	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-16	2020-06-16	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-16	2020-06-16	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-16	2020-06-16	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-16	2020-06-16	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	15,33		18.900		18.900
2020-06-05	2020-06-03	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19,7500	-40.086	-792		6.824.992
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14.157.890
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14.157.890
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14.157.890
2020-06-03	2020-06-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20,0200	-5.006	-100		6.865.078
2020-06-03	2020-06-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19,7500	-100.389	-1.983		6.870.084
2020-06-03	2020-06-01	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20,5300	-1.400	-29		6.970.473
2020-06-03	2020-06-01	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19,8500	-107.072	-2.125		6.971.873
2020-03-05	2020-03-03	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	7,66		150.000		150.000
2020-03-05	2020-03-03	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	7,66		525.000		525.000
2020-03-05	2020-03-03	4	Schroer John R.	TBIO	Stock Option (right to buy)	A - Award	D	7,66		150.000		150.000
2020-03-05	2020-03-03	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	7,66		150.000		150.000
2020-03-05	2020-03-03	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	7,66		150.000		150.000
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35.088.478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35.088.478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35.088.478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35.088.478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35.088.478
2019-07-15	2019-07-12	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	10,15		37.800		37.800
2019-06-19	2019-06-18	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-06-19	2019-06-18	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-06-19	2019-06-18	4	LYNCH DANIEL	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-06-19	2019-06-18	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-06-19	2019-06-18	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-06-19	2019-06-18	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	10,20		18.900		18.900
2019-04-26	2019-04-24	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	9,40		360.000		360.000
2019-04-11	2019-04-10	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	12,36		37.800		37.800
2019-03-12	2019-03-08	4	Schroer John R.	TBIO	Stock Option (right to buy)	A - Award	D	7,95		125.000		125.000
2019-03-12	2019-03-08	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	7,95		125.000		125.000
2019-03-12	2019-03-08	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	7,95		150.000		150.000
2019-03-12	2019-03-08	4	Cloghessy Paula	TBIO	Stock Option (right ot buy)	A - Award	D	7,95		60.000		60.000
2019-03-12	2019-03-08	4	Fenton Brian	TBIO	Stock Option (irght to buy)	A - Award	D	7,95		90.000		90.000
2019-03-12	2019-03-08	4	Heartlein Michael	TBIO	Stock Option (right to buy)	A - Award	D	7,95		150.000		150.000
2019-03-12	2019-03-08	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	7,95		500.000		500.000
2019-01-03	2019-01-02	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	7,49		37.800		37.800
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series C Preferred Stock	C - Conversion	I			-2.525.253		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series B Preferred Stock	C - Conversion	I			-7.222.797		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series A Preferred Stock	C - Conversion	I			-9.300.000		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	P - Purchase	I		13,0000	269.230	3.500		3.697.912
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			454.550			3.428.682
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			1.300.116			2.974.132
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			1.674.016			1.674.016
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Series C Preferred Stock	C - Conversion	I			-227.272		0
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Series C Preferred Stock	C - Conversion	I			-227.272		0
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock	C - Conversion	I			40.909			40.909
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Common Stock	C - Conversion	I			40.909			40.909
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-2.525.253		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-5.838.230		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-12.925.244		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Common Stock	C - Conversion	D			3.832.010			3.922.010
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-302.173		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series C Preferred Stock	C - Conversion	I			-302.173		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-2.000.103		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series B Preferred Stock	C - Conversion	I			-2.000.103		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-5.800.000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series A Preferred Stock	C - Conversion	I			-5.800.000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series C Preferred Stock	C - Conversion	I			-1.263.484		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-1.263.484		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series B Preferred Stock	C - Conversion	I			-1.676.348		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-1.676.348		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-2.500.000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series A Preferred Stock	C - Conversion	I			-2.500.000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Common Stock	C - Conversion	I			1.458.424			1.458.424
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Common Stock	C - Conversion	D			1.458.424			1.458.424
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Common Stock	C - Conversion	D			979.179			979.179
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Common Stock	C - Conversion	I			979.179			979.179
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Series C Preferred Stock	C - Conversion	D			-1.010.101		0
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Series B Preferred Stock	C - Conversion	D			-9.259.259		0
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Common Stock	P - Purchase	D		13,0000	25.000	325		1.873.503
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Common Stock	C - Conversion	D			1.848.503			1.848.503
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series C Preferred Stock	C - Conversion	I			-2.525.253		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series B Preferred Stock	C - Conversion	I			-5.838.230		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series A Preferred Stock	C - Conversion	I			-12.925.244		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock	C - Conversion	I			3.832.010			3.922.010
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series C Preferred Stock	C - Conversion	I			-2.525.253		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series B Preferred Stock	C - Conversion	I			-7.222.797		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series A Preferred Stock	C - Conversion	I			-9.300.000		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	P - Purchase	I		13,0000	269.230	3.500		3.697.912
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			454.550			3.428.682
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			1.300.116			2.974.132
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			1.674.016			1.674.016
2018-07-02	2018-07-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	J - Other	D			183.619			7.078.945
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13.790.650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13.790.650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13.790.650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13.790.650
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143.666
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143.666
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143.666
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36.000
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36.000
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36.000
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643.650
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643.650
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643.650
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59.720
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59.720
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59.720
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1.173.565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1.240.121
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1.173.565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1.240.121
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1.173.565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1.240.121
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250.990
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250.990
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250.990
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180.000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180.000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180.000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180.000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180.000
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102.480
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102.480
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102.480
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180.000
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180.000
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180.000

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

TBIO / Telesis Bio, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5